4 ms·
why I am NOT bullish on this solving molecular medicine discovery problems: medchem is notoriously NOT generalizable. A crude example is the reason why the de
by dnautics 10y ago
why I am NOT bullish on this solving molecular medicine discovery problems:
medchem is notoriously NOT generalizable. A crude example is the reason why the developed heroin is because in the early days of medchem, the reasoning was acetyl-salicylic acid is awesomer than salicylic acid, so therefore acetyl-morphine must be awesomer than morphine. Actually, in many ways it is awesomer (and that's why it's a bad drug).
Consider Gleevec. Even if you knew the structure of gleevec's target (BCR/ABL) you would not be able to predict Gleevec, because it works by displacing an entire segment of the protein out of place which happens to be thermodynamically more stable (but kinetically disfavorable). Gleevec is a medchem drug (discovered through combinatorial synthesis) but sadly the insight into this mechanism is only generalizable in the conceptual sense, if you take that molecular fragment and graft it onto another molecule intended for a different target, it probably won't work.
Deep learning depends strongly on generalizable knowledge, and medchem is notoriously not easily generalizable for well-understood reasons.
Some aspects of medchem - like optimizing bulk synthesis reactions, picking synthetic routes, guessing at bioavailability, stability in formulations, might be amenable to ML, but I am not bullish on discovery. Let's hope I'm wrong.
- refurb 10y agoI used to work in medicinal chemistry and agree 100%. It's not to say ML has no value, but predicting molecular behavior, even in the simplest system is really dam hard. Wheb you only under 10% of the factors influencing behavior, ML doesn't get you far.
- visarga 10y agoThat means they need 90% more data, right? Like, how other molecules behave in context, not stand alone. Some of them have similar properties.
- refurb 10y agoThat's true, but we don't even know what to look for to find that remaining 90% of data! I remember working with some computational scientists:"just put a methyl group on this nitrogen and we should increase binding by 100x!". So we make the molecule, give it to the biologists and find out binding is actually 1000x worse!
- dnautics 10y agoI'd put even odds on some sort of ML replacement for Lipinski's rule of five. But there are also whole classes of exceptions, like strategically methylated cyclic peptides.